GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics

The growing use of short-interfering RNA (siRNA)-based therapeutics for viral diseases reflects the most recent innovations in anti-viral vaccines and drugs. These drugs play crucial roles in the fight against many hitherto incurable diseases, the causes, pathophysiologies, and molecular processes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangamani, Lokesh, Balasubramanian, Balamuralikrishnan, Easwaran, Murugesh, Natarajan, Jeyakumar, Pushparaj, Karthika, Meyyazhagan, Arun, Piramanayagam, Shanmughavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405237/
https://www.ncbi.nlm.nih.gov/pubmed/34474100
http://dx.doi.org/10.1016/j.phrs.2021.105864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405237/
https://www.ncbi.nlm.nih.gov/pubmed/34474100
http://dx.doi.org/10.1016/j.phrs.2021.105864

Ejemplares similares